Lipopolysaccharide a virulence factor of Helicobacter pylori: Effect of antiulcer agents

Journal of Physiology and Pharmacology

Volumn 49, Issue 1, 1998, Pages 3-24

  Piotrowski, J ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Antiulcer agents; Apoptosis; Epithelial surface receptors; H. pylori; Lipopolysaccharide

Indexed keywords

ANTIULCER AGENT; BACTERIUM LIPOPOLYSACCHARIDE; CELL SURFACE RECEPTOR; EBROTIDINE; GASTRIN; GLYCOPROTEIN; LAMININ RECEPTOR; MUCIN; SCLEROPROTEIN; SOMATOSTATIN; SUCRALFATE; SULGLICOTIDE; VIRULENCE FACTOR;

APOPTOSIS; BACTERIAL VIRULENCE; DRUG EFFECT; DRUG POTENCY; GASTRITIS; HELICOBACTER PYLORI; HUMAN; NONHUMAN; REVIEW; STOMACH EPITHELIUM; STOMACH MUCOSA INJURY; STOMACH MUCUS; STOMACH PROTECTION; STOMACH ULCER;

ANTI-ULCER AGENTS; APOPTOSIS; GASTRIC MUCOSA; HELICOBACTER PYLORI; HUMANS; LIPOPOLYSACCHARIDES; MUCUS; RECEPTORS, CELL SURFACE; RECEPTORS, SOMATOSTATIN;

EID: 0031981250     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (124)

1. Warren JR, Marshall BJ. Unidentified curved bacillus on gastric epithelium in active chronic gastritis. Lancet 1983; 1: 1273-1275.
2. Marshall BJ, Warren JR. Unidentified curved bacilli in stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315.
3. Valkonen KH, Wadstrom T, Moran A. P. Interaction of lipopolysaccharides of Helicobacter pylori with basement membrane protein laminin. Infect Immun 1994; 62: 3640-3648.
4. Moran AP. Pathogenic properties of Helicobacter pylori. Scand J Gastroenterol 1996; 31: Suppl. 215: 22-31.
5. Lin S-K, Lambert JR. Helicobacter pylori in ulcerogenesis. Scand J Gastroenterol 1995; 30; Suppl. 210: 64-69.
6. Conrad RS, Kist M, Schlecht S, Galanos C. Extraction and biochemical analysis of Helicobacter pylori lipopolysaccharides. Curr. Microbiol. 1992; 24: 165-169.
7. Konturek PCh, Konturek SJ. Role of Helicobacter pylori infection in gastro-duodenal secretion and in pathogenesis of peptic ulcer and gastritis. J Physiol Pharmacol 1994; 45: 333-350.
8. Tytgat GNJ, Noach L. Rauws AJ. Helicobacter pylori. Scand J Gastroenterol 1991; 26: Suppl. 187: 1-8.
9. Goodwin CS, Armstrong JA, Chilveres T. et al. Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb, nov., respectively. Int J Syst Bacterial 1989; 39: 397-405.
10. The EUROGAST Study Group. An International association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-1362.
11. Forman D. Helicobacter pylori and gastric cancer. Scand J Gastroenterol 1996; 31: Suppl. 214: 31-33.
12. Graham DY, Opekun A, Lew GM, Evans DJ. Jr, Klein PD, Evans DG. Ablation of exaggerated meal-stimulated gastrin release in duodenal ulcer patients after clearance of Helicobacter (Campylobacter) pylori infection. Am J Gastroenterol 1990; 95: 394-398.
13. Queiroz DM, Mendes EN, Rocha GA. Effect of Helicobacter pylori eradication on antral gastrin and somatostatin immunoreactive cell density and gastrin and somatostatin concentrations. Scand J Gastroenterol 1993; 28: 858-64.
14. Lee A, Finaly M. Lambert JR, Saviono R, Soveny C., Midolo P. Antral gastrin and somatostatin cells in Helicobacter pylori subjects: restitution of D cell number with eradication. Gastroenterology 1993; 104: A1046.
15. McColl KE, El-Omar E. Effect of H. pylori infection on gastrin and gastric acid secretion. In: Helicobacter pylori: basic mechanism to clinical cure. Hunt RH, Tytgat G.H. (ed.) 1994; pp 245-56.
16. Cover TL, Dooley CP, Blaser MJ. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990; 58: 603-610.
17. Murakami A T, Yanai H. Effect of Helicobacter pylori on gastric mucosal blood flow. In: Proceedings of World Congress of Gastroenterology, Sydney, 1990.
18. Lambert JR, Lin SK, Aranda-Michel J. Helicobacter pylori. Scand J Gastroenterol 1995; 30: Suppl. 208: 33-46.
19. Moran AP, Helander IM, Kosunen IU. Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J. Bacteriol 1992; 174: 1370-1377.
20. Moran AP. Cell surface characteristics of Helicobacter pylori. FEMS Immun Med Microbiol 1995; 10: 271-280.
21. Muotiala A, Helander IM, Pyhala L, Kosunen TU, Moran AP. Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun 1992; 60: 1714-1716.
22. Brade H, Brade L, Rietschel ET. Structure-activity relationships of bacterial lipopolysaccharide (endotoxins). Current and future aspects. Zentralbl Bakteriol Mikrobiol Hyg. A 1988; 268: 151-179.
23. Weckesser J, Mayer H. Different lipid A types in lipopolysaccharides of phototrophic and related non-phototrophic bacteria. FEMS Microbiol Rev 1988; 54: 143-154.
24. Rietschel ET, Brade L, Holst O et al. Molecular structure of bacterial endotoxin in relation to bioactivity. In: Endotoxin research series Vol. 1. Cellular and molecular aspects of endotoxin reactions. Nowotny A, Spitzer JJ, Ziegler EJ (ed.) 1990; pp. 15-32.
25. Moran AP, Walsh EJ. Expression and electrophoretic characterization of smooth-form lipopolysaccharide of Helicobacter pylori. Acta Gastroenterol Belg 1993; 56 (S): 97.
26. Mattsby-Baltzer I, Mielniczuk Z, Larsson L, Lindgren K. Goodwin S. Lipid A in Helicobacter pylori. Infect Immun 1992; 60: 4383-4387.
27. Cave TR, Cave DR. Helicobacter pylori stimulates pepsin secretion from isolated rabbit gastric glands. Scand J Gastroenterol 1991; 26: Suppl. 181: 9-14.
28. Young GO, Stemmet N, Lastovica A et al. Helicobacter pylori lipopolysaccharide stimulates gastric mucosal pepsinogen secretion. Aliment Pharmacol Ther 1992; 6: 169-177.
29. Aspinall GO, Monteiro MA, Pang H, Walsh EJ, Moran AP. Lipopolysaccharide of the Helicobacter pylori type strain NCTC 11637 (ATCC 43504): structure of the O antigen chain and core oligosaccharide regions. Biochemistry 1996; 35: 2489-2497.
30. Aspinall GO, Monterio MA. Lipopolysaccharides of Helicobacter pylori strains P466 and MO19: structures of the antigen and core oligosaccharide regions. Biochemistry 1996; 35: 2498-2504.
31. Yurchenco PD, Schittny JC. Molecular architecture of basement membranes. FASEB J 1990; 4: 1577-1590.
32. Milan SB, Haskin Ch., Zardeneta G., Chen D., Magnuson V. L., and Klebe R. J. Cell adhesion protein in oral biology. Oral Biol Med 1991; 2(4): 451-491.
33. Timpl R. Structure and biological activity of basement membrane proteins. Eur J Biochem 1989; 180: 487-502.
34. Ruoslahti E, Hayman EG, Pierschbacher MD. Extracellular matrices and cell adhesion. Arteriosclerosis 1985; 5: 581-594.
35. Akiyama SK, Nagata K, Yamada KM. Cell surface receptors fo extracellular matrix components. Biochim Biophys Acta 1990; 1031: 91-110.
36. Chung AE, Jaffe R, Freemann IL, Vergnes JP, Braginski JE, Carlin B. Properties of basement membrane-related glycoprotein synthesized in culture by a mouse embryonal carcinoma-derived cell line. Cell 1979; 16: 277-281.
37. Kleinman HK, Cannon FB, Laurie GW et al. Biological activities of laminin. J Cell Biochem 1985; 27: 317-325.
38. Liotta LA, Rao CN, Wewer UM. Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem 1986; 55: 1037-1057.
39. Woodley DT, Rao CN, Hassell JR, Liotta LA, Martin GR, Kleinman HK. Interactions of basement membrane components. Biochem Biophys Acta 1983; 761: 278-283.
40. Rao CN, Marghulies IM, Liotta LA. Binding domain for laminin on type IV collagen. Biochem Biophys Res Commun 1985; 128: 45-52.
41. Laurie GW, Bing JT, Kleinman HK. et al. Localization of binding sites for laminin, heparan sulfate proteoglycan and fibronectin on basement membrane (type IV collagen. J Mol Biol 1986; 205-216.
42. Del Rosso M, Cappelleti R, Viti M, Vannucchi S, Chiarugi V. Binding of the basement-membrane glycoprotein laminin to glycosaminoglycans. An affinity-chromatography study. Biochem J 1981; 199: 699-704.
43. Yurchenco PD, Tsilibary EC, Charonis AS, Furthmayr H. Laminin polymerization in vitro. Evidence for a two-step assembly with domain specificity. J. Biol Chem 1985; 260: 7636-7644.
44. Timpl R, Rohde H, Robey PG, Rennard SI, Foidart JM, Martin GR. Laminin-a glycoprotein from basement membranes. J Biol Chem 1979; 254: 9933-9937.
45. Rao CN, Goldstein IJ, Liotta LA. Lectin-binding domains on laminin. Arch Biochem Biophys 1983; 227: 118-124.
46. Rao CN, Castronova V. Schmitt C, Wewer UM, Claysmith AP, Liotta LA, Sobel M. Evidence for a precursor of the high-affinity metastasis-associated murine laminin receptor. Biochemistry 1989; 287: 7476-7486.
47. Mecham RP. Receptors for laminin on mammalian cells. FASEB J 1991; 5: 2538-2546.
48. Gehlsen KR, Dillner L, Engvall E, Ruoslahti E. The human laminin receptor is a member of the integrin family of cell adhesion receptors. Science 1988; 241: 1228-1229.
49. Tomaselli KJ, Damsky CH. Reichardt LF. Purification and characterization of mammalian integrins expressed by rat neuronal cell line (PC 12): evidence that they function as alpha/beta heterodimeric receptors for laminin and type IV collagen. J Cell Biol 1988; 107: 1241-1252.
50. Roberts DD, Rao CN, Magnoni JL, Spitalnik SL, Liotta LA, Ginsburg V. Laminin binds specifically to sulfated glycolipids. Proc Natl Acad Sci U.S.A. 1985; 82: 1306-1310.
51. Switalski LM, Murchison R, Timpl RC, Hook M. Binding of laminin to oral and endocarditis strains of viridans streptococci. J Bacteriol 1987; 169: 1095-1101.
52. Switalski LM, Speziale P, Hook M, Wadstrom T, Timpl R. Binding of Streptococcus pyogenes to laminin. J Biol Chem 1984; 259: 3734-3738.
53. Lopes JD, Reis M, Brentani RR. Presence of laminin receptors in Staphylococcus aureus. Science 1985; 229: 275-277.
54. Westerlund B, Merenmies J, Rauvala H et al. The O75 adhesin of uropathogenic Escherichia coli. Microbiol Pathol 1987; 3: 117-128.
55. Szabo S, Pihan G, Triers S. 1986 Alteration in blood vessels during gastric injury and protection. Scand J Gastroenterol 1986; 21: Suppl. 125: 92-96.
56. Flemstrom G. Gastric and duodenal mucosal bicarbonate secretion; in: Physiology of the Gastrointestinal Tract, L. R. Johnson (ed.) 1987; pp 1011.
57. Silen W. Gastric mucosal defense and repair; In: Physiology of the Gastrointestinal Tract, L. R. Johnson (ed.) 1987; pp 1055.
58. Slomiany A, Yano S, Slomiany BL, Glass GB. Lipid composition of the gastric mucous barrier in the rat. J Biol Chem 1978; 253: 3785-3791
59. Slomiany A, Takagi A, Slomiany BL. The synthesis and secretion of gastric mucus, glycoprotein by mucosal cells cultured in the presence of ethanol. Arch Biochem Biophys 1985 236: 654-661.
60. Slomiany BL, Piasek A, Sarosiek J, Slomiany A. The role of surface and reformed intracellular mucus in gastric mucosal protection against hydrogen ion. Scand J Gastroenterol 1985; 20: 1191-1196.
61. Zalesna G, Tsukada H, Okazaki K, Slomiany BL, Slomiany A. Synthesis and initial processing of gastric apomucin. Biochem Int. 1989; 18: 775-784.
62. Lee A, Hazell SL. Campylobacter pylori in health and disease: an ecological perspective. Microb Ecol Health Dis 1988; 1: 1-16.
63. Slomiany BL, Bilski J, Sarosiek J et al. Campylobacter pyloridis degrades mucin and undermines gastric mucosal integrity. Biochem Biophys Res Commun 1987; 144: 307-314.
64. Sarosiek J, Slomiany A, Slomiany BL. Evidence for weakenning of gastric mucus integrity by Compylobacter pylori. Scand J Gastroenterol 1988; 23: 585-590.
65. Slomiany BL, Nishikawa H, Piotrowski J, Okazaki K, Slomiany A. Lipolytic activity of Campylobacter pylori: effect of sofalcone. Digestion 1989; 43: 33-40.
66. Slomiany BL, Kasinathan C, Slomiany A. Lipolytic activity of Campvlobacter pylori: effect of colloidal bismuth subcitrate (De-Nol). Am J Gastroenterol 1989; 84: 506-510.
67. Slomiany BL, Piotrowski J, Sengupta S, Slomiany A. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide. Biochem Biophys Res Commun 1991; 175: 963-970.
68. Pytela R, Pierchbacher D, Rouslahti E. Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor. Cell 1985; 40: 191-198.
69. Piotrowski J, Yamaki K, Slomiany A, Slomiany BL. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori: effect of sucralfate. Am J Gastroenterol 1991; 86: 1756-1770.
70. Rao CN, Margulies I, Tralka TS at all. Isolation of a subunit of laminin an its role in molecular structure and tumor cell attachment. J Biol Chem 1982; 257: 9740-9744.
71. Malinoff HL, Wicha MS. Isolation of a cell suface receptor protein for laminin from murine fibrosarcoma cells. J Cell Biol 1983; 96: 1474-1479.
72. Graf J, Ogle RC, Robey FA et al. A pentapeptide from the laminin B1 chain mediates cell adhesion and binds the 67,000 laminin receptor. Biochemistry 1987; 26: 6896-6900.
73. Slomiany BL, Piotrowski J, Samanta A, VanHorn K, Murty VL, Slomiany A. Compylobacter pylori colonization factor shows specificity for lactosylceramide sulfate and GM3 ganglioside. Biochem Int 1989; 19: 929-936.
74. Graham DY. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96: 615-625.
75. Hazell SL, Lee A, Brady L, Hennessy W. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis 1986; 163: 658-663.
76. Slomiany BL, Murty VLN, Piotrowski J. et al. In: Helicobacter pylori and gastric mucus integrity. Menge H, Gregor M, Tytgat GN et al. (eds.) 1990, pp 37-51.
77. 2-receptor antagonist with mucosal strengtheninig activity. Biochem Int 1992; 26: 659-667.
78. Slomiany BL, Liu J, Keogh J. Piotrowski J, Slomiany A. Enhancement of gastric mucosal epidermal growth factor and platelet-derived growth factor receptor by sucralfate. Gen Pharmacol 1992; 23: 715-718.
79. Slomiany BL, Piotrowski J, Murty VL, Slomiany A. Mechanism of ebrotidine protection against gastric mucosal injury induced by ethanol. Gen Pharmacol 1992: 23: 719-727.
80. Piotrowski J, Czajkowski A, Yotsumoto F, Slomiany A, Slomiany BL. Effect of ebrotidine on gastric mucosal EGF and PDGF receptor expression. Biochem Mol Biol Int 1993; 30: 1127-1134.
81. Slomainy BL, Piotrowski J, Mojtahed H, Slomiany A. Ebrotidine effect on the proteolytic and lipolytic activities of H. pylori. Gen Pharmacol 1992; 23: 203-206.
82. Piotrowski J, Czajkowski A, Yotsumoto F, Slomiany A, Slomiany BL. Sulglycotide effect on the proteolytic and lipolytic activities of H. pylori toward gastric mucus. Am J Gastroenterol 1994; 89: 232-236.
83. Slomiany BL, Piotrowski J, Slomiany A. Effect of sucralfate on the degradation of human gastric mucus by H. pylori protease and lipases. Am J Gastroenterol 1992; 87 (5): 595-599.
84. Piotrowski J, Murty VL, Slomiany A, Slomiany BL. Susceptibility of Helicobacter pylori to antimicrobial agents: effect of sulglycotide. Biochem Mol Biol Int 1995; 35: 467-472.
85. Piotrowski J, Piotrowski E, Slomiany A, Slomiany BL. Susceptibility of Helicobacter pylori to antimicrobial agents: effect of ebrotidine and ranitidine. J Physiol Pharmacol 1996; 46: 463-469.
86. Slomiany BL, Piotrowski J, Majka J, Slomiany A. Sucralfate affects the susceptibility of H. pylori to antimicrobial agents. Scand J Gastroenterol 1995; 30: Suppl. 210: 82-84.
87. Piotrowski J, Morita M, Slomiany A, Slomiany BL. Inhibition of gastric mucosal laminin receptor by H. pylori lipopolysaccharide; effect of ebrotidine Biochem Int 1992; 27: 131-138.
88. Piotrowski J, Czajkowski A, Yotsumoto F, Slomiany A, Slomiany BL. H. pylori lipopolysaccharide inhibition of gastric mucosal laminin receptor: effect of sulglycotide. Gen Pharmacol 1993; 24: 1467-1472.
89. Slomiany BL, Slomiany A. Role of mucus in gastric mucosal protection J Physiol Pharmacol 1991; 42: 147-161.
90. Slomiany BL, Sarosiek J, Slomiany A. Gastric mucus and th mucosal barrier. Dig Dis 1987; 5: 125-145.
91. Neutra MR, Forstner JF. Gastrointestinal mucins synthesis secretion and function. In: Physiology of the Gastrointestinal Tract. Johnson L. R. (ed.) Vol. 2, 1987 pp. 975-1009.
92. Slomiany BL, Piotrowski J, Czajkowski A, Murty VL, Slomiany A. Characterization of gastric mucosal mucin receptor. Biochem Mol Biol Int 1993; 31: 745-753.
93. Liau YH, Lopez RA, Slomiany A, Slomiany BL. Helicobacter pylori lipopolysaccharide effect on synthesis and secretion of sulfated gastric mucin. Biochem Biophys Res Commun 1992; 184: 1411-1417.
94. Piotrowski J, Slomiany A, Slomiany BL. Inhibition of gastric mucosal mucin receptor by H. pylori lipopolysaccharide. Biochem Mol Biol Int 1993; 31: 1051-1059.
95. Marshall BJ. Campylobacter pyloridis and gastritis. J Infect Dis 1986; 153: 650-657.
96. Blaser NJ. Gastric Campylobacter - like organisms, gastritis and peptic ulcer disease. Gastroenterology 1987; 93: 371-383.
97. Graham DY. Campylobacter pylori and peptic ulcer disease Gastroenterology 1989; 96: 615-625.
98. Piotrowski J, Majka J, Murty LV, Czajkowski A, Slomiany A, Slomiany BL. Inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide; effect of sulglycotide. Gen Pharmacol 1994; 25: 969-976.
99. Slomiany A, Piotrowski J, Slomiany BL. Sucralfate counteracts the inhibition of gastric mucosal mucin receptor by Helicobacter pylori lipopolysaccharide. Scand J Gastroenterol 1995; 30: Suppl. 210: 77-81.
100. 2-receptor antagonists. Eur J Med Chem 1988; 23: 97-100.
101. 2-receptor antagonist, ebrotidine. Digestion 1992; 51: 27-36.
102. 2-receptor antagonist with local gastroprotective activity. Eur J Gastroenterol Hepat 1992; 3: 941-947.
103. Slomiany BL, Lopez RA, Liau YH, Slomiany A. Effect of ebrotidine on the synthesis and secretion of gastric sulfomucin. Gen Pharmacol 1993; 24: 611-617.
104. Gabryelewicz A, Konturek SJ, Butruk G et al. Comparison of the efficacy and safety of ebrotidine and ranitidine in the treatment of duodenal ulcer. Gastroenterology 1994; 106: A79.
105. Slomiany BL, Piotrowski J, Murty VL, Slomiany A. Inhibition of gastric mucosal mucin receptor by H. pylori lipopolysaccharide: effect of ebrotidine. Gen Pharmacol 1995; 26: 1553-1558.
106. McHenry L, Vuyyuru L, Schubert ML. Helicobacter pylori and duodenal ulcer disease: the somatostatin link? Gastroenlerology 1993; 104: 1573-1575.
107. Graham DY, Lew GM, Leckago J. G-cell and D-cell numbers in Helicobacter pylori infection: effect of H. pylori eradication. Gastroenterology 1993; 104: 1655-1660.
108. Tarnasky PR, Kovacs TO, Sytnik B. Asymptomatic H. pylori infection impairs pH inhibition of gastrin and acid secretion during second hour of peptone meal stimulation. Dig Dis Sci 1993: 38: 1681-1687.
109. Haruma K, Sumii K, Okamoto S, Yoshihara M, Sumi M. Kajyama G, Wagner S. Helicobacter pylori infection is associated with low antral somatostatin content in young adults; implication for the pathogenesis of hypergastrinemia. Scand J Gasiroenterol 1995; 30: 550-553.
110. Konturek JW, Bielanski W, Konturek SJ. Domschke W. Eradication of Helicobacter pylori restores the inhibitory effect of gastric paracrine somatostatin on gastric acid secretion in duodenal ulcer patients. Gastroenterologe 1997: 112: A181.
111. Piotrowski J, Majka J, Slomiany A. Slomiany BL. Helicobacter pylori lipopolysaccharide inhibiton of gastric mucosal samatostatin receptor. Biochem Mol Biol Int 1995; 36: 491-498.
112. Moss SF, Legon S, Bishop A. Polak JM, Calam J. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992; 340: 930-932.
113. Piotrowski J, Skrodzka D, Slomiany A, Slomiany BL. Reversal of gastric somatostatin receptor inhibition by H. pylori lipopolysaccharide with ebrotidine and sulglycotidc. Gen Pharmacol 1997; 28: 705-708.
114. Piotrowski J, Slomiany A Slomiany BL. Helicobacter pylori lipopolysaccharide inhibition of gastric somatostatin receptor: effect of sucralfate. Biochem Mol Biol Int 1997: in press.
115. Robert ME, Weinstein WM. Helicobacter pylori-associated gastric pathology. Gastroenterol Clin North Am 1993; 22: 59-72.
116. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
117. Hall PA, Coates PJ, Ansari A, Hopwood D. Regulation of cell number in the mammalian gastrointestinal tract: the importance of apoptosis. J Cell Sci 1994; 107: 3569-3577.
118. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995: 267: 456-1462.
119. Moss SF, Calam J, Agarawal B, Wang S, Holt PR. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996; 38: 498-501.
120. Jones NI, Yeger H, Cutz E, Sherman PM. Helicobacter pylori induces apoptosis of gastric antral epithelial cells in vivo. Gastroenterology 1996; 110: A933.
121. Stolte M, Edit S. Helicobacter pylori and the evolution of gastritis. Scand J Gastroenterol 1996; 31: Suppl. 214: 13-16.
122. Piotrowski J, Skrodzka D, Slomiany A, Slomiany BL. Helicobacter pylori lipopolysaccharide induces gastric epithelial apoptosis. Biochem Mol Biol Int 1996; 40: 597-602.
123. Piotrowski J, Piotrowski E, Skrodzka D, Slomiany A. Slomiany BL. Induction of acute gastritis and epithelial apoptosis by Helicobacter pylori lipopolysaccharide. Scand J Gastroeterol 1997; 32: 203-211.
124. Psilogenis M, Aberico P, Bianchi G. Nazzari M. Sulglycotide. In: Drugs in Gastroenterology. Braga PD (ed.) 1994; pp. 232-244.